Difference between revisions of "DZI20-210-Case-21"

From MGH Learn Pathology
(Edited automatically from page DZI20-210.)
(Added status template)
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{dziCase
+
{{ServiceRequestCase
|qc=yes
+
|identifier=DZI20-210-Case-21
|qcuser=Aja51
+
|intent=order
|qctime=Oct 26, 2020 14:54:33
+
|category=409073007
|order_date=October 21, 2020 03:15:36 PM
+
|priority=routine
|user=Vn048
+
|orderDetail=case
|dziorder=DZI20-210
+
|locationCode=learn
|case_id=21
+
|basedOn=DZI20-210
|publish_timestamp=Choose_date 13:00
+
|code=faculty
|clinical_hx=NA
+
|supportingInfo=SKIN, LEFT LATERAL THIGH, SHAVE BIOPSY, GAMMA DELTA T CELL LYMPHOMA.
|case_diagnosis=SKIN, LEFT LATERAL THIGH, SHAVE BIOPSY, GAMMA DELTA T CELL LYMPHOMA.
 
  
 
IHC: atypical lymphocytes are negative for CD4 and CD8, expressing a gamma-delta T cell phenotype, positive for CD3 and CD7 with partial loss of CD5 expression. CD56 is negative; partial expression of TIA-1 and granzyme B is noted. BF1 (alpha/beta TCR) is negative. Numerous large cells are positive for CD30 (15%). In situ hybridization for EBV remained negative. Molecular analysis revealed a clonal rearrangement of the T cell gamma receptor.
 
IHC: atypical lymphocytes are negative for CD4 and CD8, expressing a gamma-delta T cell phenotype, positive for CD3 and CD7 with partial loss of CD5 expression. CD56 is negative; partial expression of TIA-1 and granzyme B is noted. BF1 (alpha/beta TCR) is negative. Numerous large cells are positive for CD30 (15%). In situ hybridization for EBV remained negative. Molecular analysis revealed a clonal rearrangement of the T cell gamma receptor.
 +
|reasonCode=NA
 +
|subject=MGH
 +
|performer=VN048
 +
|authoredOn=October 21, 2020 03:15:36 PM
 +
|requester=Vn048
 +
|sequence=21
 +
|access=public
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=October 21, 2020 03:15:36 PM
+
|basedOn=DZI20-210-Case-21
|user=Vn048
+
|type=image
|source_filename=Z0FBQUFBQmZrRkNiR1FUMG14U0JkN3ROU2p5Z2s3VHg5c1oyX0dYR3JvUHV5V29xaW03aWlNRmVmdm9mNnFFYzBKa3pydmc1ZjhNZnQyaUR6M1NSeTlrN0JJbVU2bUdid3c9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-210
|slide_anatomy=Show
+
|frames=1
 +
|reasonCode=H&E
 +
|identifier=DZI20-210-Case-21_1
 +
|createdDateTime=October 21, 2020 03:15:36 PM
 +
|operator=Vn048
 +
|subject=Z0FBQUFBQmZrRkNiR1FUMG14U0JkN3ROU2p5Z2s3VHg5c1oyX0dYR3JvUHV5V29xaW03aWlNRmVmdm9mNnFFYzBKa3pydmc1ZjhNZnQyaUR6M1NSeTlrN0JJbVU2bUdid3c9PQ
 +
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Vn048
 +
|authoredOn=October 21, 2020 03:15:36 PM
 
}}
 
}}

Latest revision as of 14:01, December 9, 2024

DZI20-210-Case-21
NA
SKIN, LEFT LATERAL THIGH, SHAVE BIOPSY, GAMMA DELTA T CELL LYMPHOMA. IHC: atypical lymphocytes are negative for CD4 and CD8, expressing a gamma-delta T cell phenotype, positive for CD3 and CD7 with partial loss of CD5 expression. CD56 is negative; partial expression of TIA-1 and granzyme B is noted. BF1 (alpha/beta TCR) is negative. Numerous large cells are positive for CD30 (15%). In situ hybridization for EBV remained negative. Molecular analysis revealed a clonal rearrangement of the T cell gamma receptor.
December 31, 1969 7:00:00 PM